Pharmacokinetics of a natural hybrid-hydrogel formulation of palmitoylethanolamide (PEA): randomized, single-dose, double-blinded, 2-way crossover study
Palmitoylethanolamide (PEA) is an endogenous lipid having the ability to suppress inflammatory responses, restore homeostasis, and modulate pain sensitivity. However, its concentration in the body is often limited, especially on aging, owing to low production and rapid metabolism. PEA supplementatio...
Saved in:
| Main Authors: | Maria Jose Louis, Ashil Joseph, Umesh Kannamangalam Vijayan, Abhilash Balakrishnan, Krishnakumar Illathu Madhavamenon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | CyTA - Journal of Food |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19476337.2025.2516484 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review
by: Giustino Varrassi, et al.
Published: (2024-12-01) -
Fixed combination of palmitoylethanolamide and melatonin in preventive therapy of migraine: results from a randomized clinical trial
by: Vincenzo Piccolo, et al.
Published: (2025-04-01) -
Palmitoylethanolamide: A Multifunctional Molecule for Neuroprotection, Chronic Pain, and Immune Modulation
by: Valeria Di Stefano, et al.
Published: (2025-05-01) -
The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin—A Randomized, Controlled, Crossover Study
by: Liva K. Stuhr, et al.
Published: (2025-01-01) -
Chronic palmitoylethanolamide administration via slow-release subcutaneous pellets promotes neuroprotection and mitigates neuroinflammation in the Tg2576 mouse model of Alzheimer’s disease
by: Daniel Tortolani, et al.
Published: (2025-04-01)